Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Public ClinicalTrials.gov record NCT01908192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy OF NaBen® , A D-Amino Acid Oxidase Inhibitor, as an Add-on Treatment for Schizophrenia in Adolescents
Study identification
- NCT ID
- NCT01908192
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- SyneuRx International (Taiwan) Corp
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- NaBen® Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2014
- Primary completion
- Oct 25, 2023
- Completion
- Oct 25, 2023
- Last update posted
- May 8, 2024
2014 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research | Dothan | Alabama | 36303 | — |
| CiTrials | Bellflower | California | 90706 | — |
| Renew Behavioral Health, Inc. | Long Beach | California | 90807 | — |
| CiTrials | Riverside | California | 92506 | — |
| Institute of Living/Hartford Hospital | Hartford | Connecticut | 06106 | — |
| Children's National Health System | Washington D.C. | District of Columbia | 20010 | — |
| Premier Clinical Research Institute | Miami | Florida | 33122 | — |
| Medical Research Group of Central Florida | Orange City | Florida | 32763 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| John Hopkins University - Hugo W Moser Research Institute at Kennedy Krieger Inc. | Baltimore | Maryland | 21287 | — |
| University of Massachusetts Medical School - Psychiatry Department | Worcester | Massachusetts | 01655 | — |
| Michigan Clinical Research Institute | Ann Arbor | Michigan | 48105 | — |
| University of Minnesota Medical Center - Department of Psychiatry | Minneapolis | Minnesota | 55454 | — |
| Precise Research Centers | Flowood | Mississippi | 39232 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| University of Cincinnati - Dept. of Psychiatry and Behavioral Neuroscience | Cincinnati | Ohio | 45219 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Focus and Balance LLC | San Antonio | Texas | 78229 | — |
| Pacific Institute of Medical Sciences | Bothell | Washington | 98011 | — |
| Zain Research, LLC | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01908192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01908192 live on ClinicalTrials.gov.